Anticancer principles from medicinal Piper (Hú Jiāo) plants

Journal of Traditional and Complementary Medicine

Volumn 4, Issue 1, 2014, Pages 8-16

  Wang, Yue Hu ^a,b   Morris Natschke, Susan ^a   Yang, Jun ^b   Niu, Hong Mei ^b   Long, Chun Lin ^b,c   Lee, Kuo Hsiung ^a,d  

^a University of North Carolina   (United States)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c MINZU UNIVERSITY OF CHINA   (China)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Amide alkaloids; Anticancer; Cytotoxicity; Piper; Piperaceae

Indexed keywords

EID: 84894548008     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.4103/2225-4110.124811     Document Type: Article

References (86)

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012;75:311-35.
2. Tseng YC, Xia NH, Gilbert MG. Flora of China. Vol. 4, Beijing/St. Louis: Science Press/Missouri Botanical Garden Press; 1999. p. 110-29.
3. Editorial Board of 'Zhong Hua Ben Cao', State Administration of Traditional Chinese Medicine of the People's Republic of China. Zhong Hua Ben Cao. Vol. 3, Shanghai: Shanghai Scientific and Technical Publishers; 1999. p. 424-49.
4. Li SM, Long CL, Liu FY, Lee S, Guo Q, Li R, et al. Herbs for medicinal baths among the traditional Yao communities of China. J Ethnopharmacol 2006;108:59-67.
5. Zheng XL, Xing FW. Ethnobotanical study on medicinal plants around Mt.Yinggeling, Hainan Island, China. J Ethnopharmacol 2009;124:197-210.
6. Peng CZ, Qi JJ, Li XE. Medicinal plants traditionally used by Hani people in Yuanyang, Yunnan, China. Lishizhen Med Mater Med Res 2010;21:428-31.
7. Long CL, Li R. Ethnobotanical studies on medicinal plants used by the Red-headed Yao People in Jinping, Yunnan Province, China. J Ethnopharmacol 2004;90:389-95.
8. Liu HX, Chen K, Sun QY, Yang FM, Hu GW, Wang YH, et al. Nudibaccatumone, a trimer comprising a phenylpropanoid and two sesquiterpene moieties from Piper nudibaccatum. J Nat Prod 2013;76:732-6.
9. Yang SX, Sun QY, Yang FM, Hu GW, Luo JF, Wang YH, et al. Sarmentosumols A to F, new mono-and dimeric alkenylphenols from Piper sarmentosum. Planta Med 2013;79:693-6.
10. Yang J, Su Y, Luo JF, Gu W, Niu HM, Li Y, et al. New amide alkaloids from Piper longum fruits. Nat Prod Bioprospect 2013;3:277-81.
11. Tang GH, Chen DM, Qiu BY, Sheng L, Wang YH, Hu GW, et al. Cytotoxic amide alkaloids from Piper boehmeriaefolium. J Nat Prod 2011;74:45-9.
12. Mahanta P, Ghanim A, Gopinath K. Chemical constituents of Piper sylvaticum (Roxb) and Piper boehmerifolium (Wall). J Pharm Sci 1974;63:1160-1.
13. Xin YW, Qi WD, Han CY. Traditional Chinese medicine for treating respiratory cancer. CN Patent: 101455834 A, 2009.
14. Chen TC. Observation of the medicine made by oneself in treating with 97 cases with gastric diseases. J Pract Med Technol 2008;15:593-4.
15. Alonso-Castro AJ, Villarreal ML, Salazar-Olivo LA, Gomez-Sanchez M, Dominguez F, Garcia-Carranca A. Mexican medicinal plants used for cancer treatment: Pharmacological, phytochemical and ethnobotanical studies. J Ethnopharmacol 2011;133:945-72.
16. Calderón ÁI, Vázquez Y, Solís PN, Caballero-George C, Zacchino S, Gimenez A, et al. Screening of Latin American plants for cytotoxic activity. Pharm Biol 2006;44:130-40.
17. Orjala J, Wright AD, Behrends H, Folkers G, Sticher O, Rüegger H, et al. Cytotoxic and antibacterial dihydrochalcones from Piper aduncum. J Nat Prod 1994;57:18-26.
18. Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci 2013;48:453-63.
19. Kuete V, Sandjo LP, Wiench B, Efferth T. Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol 2013;149:245-53.
20. Kuete V, Krusche B, Youns M, Voukeng I, Fankam AG, Tankeo S, et al. Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol 2011;134:803-12.
21. Pedersen ME, Metzler B, Stafford GI, Van Staden J, Jäger AK, Rasmussen HB. Amides from Piper capense with CNS activity: A preliminary SAR analysis. Molecules 2009;14:3833-43.
22. Umadevi P, Deepti K, Venugopal DV. Synthesis, anticancer and antibacterial activities of piperine analogs. Med Chem Res 2013;22:5466-71.
23. Daoudi A, El Youbl AE, Bagrel D, Aarab L. In vitro anticancer activity of some plants used in Moroccan traditional medicine. J Med Plants Res 2013;7:1182-9.
24. Usia T, Watabe T, Kadota S, Tezuka Y. Potent CYP3A4 inhibitory constituents of Piper cubeba. J Nat Prod 2005;68:64-8.
25. Kreuter MH, Yam J, Berger-Büter K. The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases. WO Patent: 2009021347, 2009.
26. Yam J, Kreuter M, Drewe J. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth? Planta Med 2008;74:33-8.
27. Holdsworth D, Kerenga K. A survey of medicinal plants in the Simbu Province, Papua New Guinea. Pharm Biol 1987;25:183-7.
28. Orjala J, Mian P, Rali T, Sticher O. Gibbilimbols A-D, cytotoxic and antibacterial alkenylphenols from Piper gibbilimbum. J Nat Prod 1998;61:939-41.
29. Soladoye MO, Amusa N, Raji-Esan S, Chukwuma E, Taiwo A. Ethnobotanical survey of anti-cancer plants in Ogun State, Nigeria. Ann Biol Res 2010;1:261-73.
30. Holdsworth D. Traditional medicinal plants of Rarotonga, Cook Islands. Part II. Pharm Biol 1991;29:71-9.
31. Kim KH, Choi JW, Choi SU, Ha SK, Kim SY, Park HJ, et al. The chemical constituents of Piper kadsura and their cytotoxic and anti-neuroinflammtaory activities. J Enzyme Inhib Med Chem 2011;26:254-60.
32. Desai SJ, Prabhu BR, Mulchandani NB. Aristolactams and 4,5-dioxoaporphines from Piper longum. Phytochemistry 1988;27:1511-5.
33. Chaveerach A, Mokkamul P, Sudmoon R, Tanee T. Ethnobotany of the genus Piper (Piperaceae) in Thailand. Ethnobot Res Appl 2006;4:223-31.
34. Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine 2011;19:83-7.
35. Bourdy G, DeWalt SJ, de Michel LR, Roca A, Deharo E, Munoz V, et al. Medicinal plants uses of the Tacana, an Amazonian Bolivian ethnic group. J Ethnopharmacol 2000;70:87-109.
36. Widowati W, Wijaya L, Wargasetia TL, Bachtiar I, Yelliantty Y, Laksmitawati DR. Antioxidant, anticancer, and apoptosis-inducing effects of Piper extracts in HeLa cells. J Exp Integr Med 2013;3:225-30.
37. Mahavorasirikul W, Viyanant V, Chaijaroenkul W, Itharat A, Na-Bangchang K. Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro. BMC Complement Altern Med 2010;10:55.
38. Diaz LE, Munoz DR, Prieto RE, Cuervo SA, Gonzalez DL, Guzman JD, et al. Antioxidant, antitubercular and cytotoxic activities of Piper imperiale. Molecules 2012;17:4142-57.
39. Chavez P, Sanchez I, González F, Rodríguez J, Axelrod F. Cytotoxicity correlations of Puerto Rican plants using a simplified brine shrimp lethality screening procedure. Pharm Biol 1997;35:222-6.
40. Li X, Liu Z, Xu X, Blair CA, Sun Z, Xie J, et al. Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice. PloS One 2012;7:e31213.
41. Ee GC, Lim CM, Lim CK, Rahmani M, Shaari K, Bong CF. Alkaloids from Piper sarmentosum and Piper nigrum. Nat Prod Res 2009;23:1416-23.
42. Roy UB, Vijayalaxmi KK. Evaluation of in vitro antitumor property of ethanolic extract of Piper Nigrum seeds. Int J Innov Res Stud 2013;2:282-302.
43. Taylor P, Arsenak M, Abad MJ, Fernandez A, Milano B, Gonto R, et al. Screening of Venezuelan medicinal plant extracts for cytostatic and cytotoxic activity against tumor cell lines. Phytother Res 2013;27:530-9.
44. Zainal Ariffin SH, Wan Omar WH, Zainal Ariffin Z, Safian MF, Senafi S, Megat Abdul Wahab R. Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell line. Cancer Cell Int 2009;9:6.
45. Scott IM, Jensen HR, Philogene BJ, Arnason JT. A review of Piper spp. (Piperaceae) phytochemistry, insecticidal activity and mode of action. Phytochem Rev 2008;7:65-75.
46. Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, et al. Phytochemistry of the genus Piper. Phytochemistry 1997;46:597-673.
47. Kato MJ, Furlan M. Chemistry and evolution of the Piperaceae. Pure Appl Chem 2007;79:529-38.
48. Rao VR, Suresh G, Babu KS, Raju SS, Vishnu vardhan MV, Ramakrishna S, et al. Novel dimeric amide alkaloids from Piper chaba Hunter: Isolation, cytotoxic activity, and their biomimetic synthesis. Tetrahedron 2011;67:1885-92.
49. Bezerra DP, Militão GC, De Castro FO, Pessoa C, de Moraes MO, Silveira ER, et al. Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. Toxicol In Vitro 2007;21:1-8.
50. Han SS, Son DJ, Yun H, Kamberos NL, Janz S. Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro. Leukemia Res 2013;37:146-54.
51. Han SS, Tompkins VS, Son DJ, Kamberos NL, Stunz LL, Halwani A, et al. Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells. Biochem Biophys Res Commun 2013;436:660-5.
52. Duh CY, Wu YC, Wang SK. Cytotoxic pyridone alkaloids from the leaves of Piper aborescens. J Nat Prod 1990;53:1575-7.
53. Bezerra DP, Pessoa C, de Moraes MO, Silveira ER, Lima MS, Elmiro FM, et al. Antiproliferative effects of two amides, piperine and piplartine, from Piper species. Z Naturforsch C 2005;60:539-43.
54. Duh CY, Wu YC, Wang SK. Cytotoxic pyridone alkaloids from Piper aborescens. Phytochemistry 1990;29:2689-91.
55. Chen JJ, Duh CY, Huang HY, Chen IS. Cytotoxic constituents of Piper sintenense. HeIv Chim Acta 2003;86:2058-64.
56. Chen JJ, Huang YC, Chen YC, Huang YT, Want SW, Peng CY, et al. Cytotoxic amides from Piper sintenense. Planta Med 2002;68:980-5.
57. Ee GCL, Lim CM, Rahmani M, Shaari K, Bong CF. Pellitorine, a potential anti-cancer lead compound against HL60 and MCF-7 cell lines and microbial transformation of piperine from Piper Nigrum. Molecules 2010;15:2398-404.
58. Ma J, Jones SH, Marshall R, Johnson RK, Hecht SM. A DNA-damaging oxoaporphine alkaloid from Piper caninum. J Nat Prod 2004;67:1162-4.
59. Elban MA, Chapuis JC, Li M, Hecht SM. Synthesis and biological evaluation of cepharadiones A and B and related dioxoaporphines. Bioorg Med Chem 2007;15:6119-25.
60. Valadares MC, de Carvalho IC, de Oliveira Junior L, Vieira Mde S, Benfica PL, de Carvalho FS, et al. Cytotoxicity and antiangiogenic activity of grandisin. J Pharm Pharmacol 2009;61:1709-14.
61. Lopes AP, Bagatela BS, Rosa PC, Nanayakkara DN, Tavares Carvalho JC, Maistro EL, et al. Antioxidant and cytotoxic effects of cude extract, fractions and 4-nerolidylcathecol from aerial parts of Pothomorphe umbellata L. (Piperaceae). Biomed Res Int 2013;2013:206581.
62. Mongelli E, Romano A, Desmarchelier C, Coussio J, Ciccia G. Cytotoxic 4-nerolidylcatechol from Pothomorphe peltata inhibits topoisomerase I activity. Planta Med 1999;65:376-8.
63. Tabudravu JN, Jaspars M. Anticancer activities of constituents of kava (Piper methysticum). S Pac J Nat Appl Sci 2005;23:26-9.
64. Ji T, Lin C, Krill LS, Eskander R, Guo Y, Zi XL, et al. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis. Mol Cancer 2013;12:55.
65. Eskander RN, Randall LM, Sakai T, Guo Y, Hoang B, Zi X. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. J Orthop Res 2012;38:1086-94.
66. Tang YX, Li XB, Liu ZB, Simoneau AR, Xie J, Zi XL. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer 2010;127:1758-68.
67. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li XY, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011;475:231-4.
68. Lin E, Lin WH, Wang SY, Chen CS, Liao JW, Chang HW, et al. Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo. J Nutr Biochem 2012;23:368-78.
69. Bi Y, Liu JH, Luo R, Wang QS, Wu X. Simultaneous determination of piperine and piperlongumine in Piper longum by HPLC. Chin J Exper Tradit Med Formulae 2012;18:47-50.
70. Adams DJ, Dai MJ, Pellegrino G, Wagner BK, Stern AM, Shamji AF, et al. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc Natl Acad Sci USA 2012;109:15115-20.
71. Adams DJ, Boskovic ZV, Theriault JR, Wang AJ, Stern AM, Wagner BK, et al. Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death. ACS Chem Biol 2013;8:923-9.
72. Liu JM, Pan F, Li L, Liu QR, Chen Y, Xiong XX, et al. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 2013;437:87-93.
73. Wang Y, Wang J, Xiao X, Shan Y, Xue B, Jiang G, et al. Piperlongumine induces autophagy by targeting p38 signaling. Cell Death Dis 2013;4:e824.
74. Jarvius M, Fryknas M, D'Arcy P, Sun C, Rickardson L, Gullbo J, et al. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun 2013;431:117-23.
75. Golovine KV, Makhov PB, Teper E, Kutikov A, Canter D, Uzzo RG, Kolenko VM. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. The Prostate 2013;73:23-30.
76. Randhawa H, Kibble K, Zeng H, Moyer M, Reindl K. Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol in Vitro 2013;17:1626-33.
77. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;302:645-50.
78. Hwang YP, Yun HJ, Kim HG, Han EH, Choi JH, Chung YC, et al. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKC alpha/ERK1/2-dependent matrix metalloproteinase-9 expression. Toxicol Lett 2011;203:9-19.
79. Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, et al. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem 2013;141:2591-9.
80. Yaffe PB, Doucette CD, Walsh M, Hoskin DW. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells. Exp Mol Pathol 2013;94:109-14.
81. Ouyang DY, Zeng LH, Pan H, Xu LH, Wang Y, Liu KP, et al. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food Chem Toxicol 2013;60:424-30.
82. Steiner G. The correlation between cancer incidence and kava consumption. Hawaii Med J 2000;59:420-2.
83. Chen GG, Lai PB. Novel apoptotic regulators in carcinogenesis. Berlin: Springer; 2012. p. 189-204.
84. Dharmaratne RW, Nanayakkara NP, Khan IA. Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses. Phytochemistry 2002;59:429-33.
85. Sakai T, Eskander RN, Guo Y, Kim KJ, Mefford J, Hopkins J, et al. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res 2012;30:1045-50.
86. An J, Gao Y, Wang J, Zhu Q, Ma Y, Wu J, et al. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway. Biotechnol Lett 2012;34:1781-8.